What if the food you eat could save your life?
At the crossroads of medical research and dietary science, Gleipnir Medical is pioneering a new paradigm: cancer treatment through groundbreaking precision nutrition. Cancer is perhaps the most researched human disease. We are convinced that personalized medical nutrition might hold the key to combating it effectively.
While studying cellular mechanics, we've recognized a fascinating phenomenon. While many cancer cells harbor mutations in pathways crucial for synthesizing certain Non-Essential Amino Acids (NEAAs), they continue to thrive in typical dietary environments, where all NEAAs are readily available. In simpler terms, these mutations don't pose a threat to cancer cells when we consume our regular diets. However, imagine creating a shift in this metabolic environment, introducing a diet that deliberately lacks certain NEAAs. This new environment could prove hostile to cancer cells, while normal cells remain unaffected. These regular cells either adapt by producing the absent amino acids or enter a state of temporary dormancy, ensuring their survival.
Our work at Gleipnir Medical is anchored in this principle. By strategically utilizing precision nutrition, we craft diets that curtail the availability of specific nutrients, thereby making the internal environment inhospitable for tumor cells. This approach of anti-cancer nutrition isn't just about starving the rogue cells but also fortifying the body to support overall health.
Through personalized medical nutrition, we're stepping into an era where each patient receives a dietary blueprint tailored to enhance their treatment. It’s more than just sustenance; it's a calculated strategy to weaponize our dietary intake against the formidable enemy of cancer.
With our dedication to this innovative blend of anti-cancer nutrition and precision dietary strategies, Gleipnir Medical is reshaping the narrative on cancer treatment. We invite you to join us, envisioning a future where the meals on our table become powerful allies in our fight against cancer.
Patents pending: PCT/EP2023/073309, EP23383102.3, EP23383100.7
Gabriel Mora, PhD
Chief Researcher and Co-founder
Dr. Gabriel Mora graduated in chemistry from the National University of Colombia, completed his master’s and PhD degrees at the International Max Planck Research School for Molecular Biology in Goettingen, Germany, and conducted postdoctoral research at the Centre for Genomic Regulation in Barcelona. He has 20 years of experience covering an ample range of topics in metabolism, biotechnology, and biomedicine.
During his graduate studies, he worked on protein and metabolic engineering for the production of nutritionally relevant animal lipids in microorganisms, as well as on the elucidation of metabolic pathways, leading to the identification of neutral lipid metabolism as a central mediator in the equilibrium of cellular phospholipid pools.
During his postdoctoral work, he researched protein secretion, protein degradation, the homeostasis of cellular membranes, and the biogenesis of organelles, including the study of molecular markers and cellular processes related to metabolic diseases such as lipodystrophy, diabetes, or obesity. Among the most significant findings of this work was the identification of molecular mechanisms that control the assembly and differentiation of lipid droplets.
Having both the reductionist perspective of a chemist and the integrative perspective of a biologist, as well as experience in both basic and applied research on a diverse spectrum of problems and contexts, provides him the scientific versatility necessary to tackle this complex, multifaceted project and the experience that earn him respect as the leader of the research team.
Esther Paulo, PhD
Researcher
Dr. Esther Paulo Mirasol is a molecular biologist with more than 10 years of research experience in biomedicine, microbiology, aging, and metabolism. Her primary research interest lies in the intricate relationship between diet, metabolism, and health. Specifically, she investigates how dietary changes impact overall health. She has worked with a broad spectrum of model organisms, ranging from microbes to mammalian cells and mice.
During her Ph.D. studies, she investigated how the fission yeast S. pombe copes with oxidative stress, an inevitable byproduct of many metabolic processes. In her postdoctoral training, she shifted her focus to understanding the role of adipocytes (fat cells) in regulating mammalian metabolism. Using a wide range of experimental approaches, including mouse models, primary cell cultures, and proteomics, she identified a new mechanism by which dietary interventions such as low-protein diets improve metabolic health. This groundbreaking discovery has opened new avenues for the development of strategies to combat metabolic diseases such as obesity.
Overall, her extensive experience in biomedicine and metabolic research makes her a strong asset for the development and testing of new dietary interventions.
Cristina Corral, PhD
Researcher
Dr. Cristina Corral-Ramos, PhD in biosciences. More than 12 years of experience in biology research give her a deep understanding of molecular biology and protein biochemistry.
Her PhD was focused on pathogenesis, looking for biological processes that affect the infecting ability to design antifungal compounds. After that, she focused on cell cycle and oxidative stress in yeast, focusing on biological processes involved in protein degradation and proteostasis, especially autophagy, a process that triggers degradation in response to nutrient depletion. However, her curiosity led her to investigate the response to viral infections and its relationship with stress in animal cell cultures.
Recently, Cris has demonstrated her capability to leverage her skills in a biotechnological project to enhance beer fermentation through wild yeast strains sourced from nature. Her expertise is particularly valuable in our current biotechnology project, given her profound understanding of biological processes, proficiency with molecular engineering tools, and experience with animal cells.
Omar Tomàs Gilabert
Lab Technician
Omar Tomàs Gilabert is a molecular biologist with over eight years of research experience in microbiology, biomedicine, and crystallography. During his doctoral studies, he examined several protein structures of the Mengla dianlovirus, a Filoviridae virus closely related to the Ebola virus.
For the first time, he uncovered the quaternary structure of some of these proteins. Throughout his training, he had the opportunity to work with a diverse range of model organisms, including bacteria, yeast, fish, and mice, as well as mammalian cell cultures such as those from bats mice, and humans. His experience spans additional fields like ecology, biodiversity conservation, and even paleontology, endowing him with remarkable versatility and proficiency in various techniques.
Zoltan Toth-Czifra
CEO and Co-founder
Zoltan Toth-Czifra is a software engineer turned entrepreneur. He earned his first software engineering paycheck at the age of 15, and later went on to study at the Budapest University of Technology and Economics and subsequently dropped out. He moved to Spain and started working at various internet companies as software developer, later manager and Chef Product Officer.
In 2016 we founded an e-commerce company based on astronomical algorithms he developed that were later validated by a NASA astronomer. He created an entirely new product category that did not exist before: commemorative, scientifically validated astronomical maps. Zoltan built a team of 8 people while running product development and marketing. His bootstrapped company reached US$9 million annual revenue and a total of 400,000 units sold globally. In 2022 the company was acquired.
Zoltan completed a BSc in Computing and Information System at the University of London and currently enrolled at a MSc program in Software Engineering at the University of Oxford, having completed the program with his project work pending.